Opendata, web and dolomites

TransGeno SIGNED

The ERA Chair for Translational Genomics and Personalized Medicine

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TransGeno project word cloud

Explore the words cloud of the TransGeno project. It provides you a very rough idea of what is the project "TransGeno" about.

therapies    hire    tg    estonia    researcher    stakeholders    sharing    ut    ages    disease    gold    treat    green    becomes    symptoms    data    doctors    era    tartu    popularize    clusters    standards    scenarios    prognostics    additional    forge    underlying    sustainable    onset    first    genomics    live    innovations    business    disorders    chair    international    young    team    scientists    people    excellence    public    spur    cancer    understand    form    efficient    health    transgeno    efforts    genomic    patients    eastern    explore    engage    coordinate    ways    curriculum    causes    neurological    youth    implementing    components    attract    world    everyday    diseases    diabetes    longer    genetic    chronic    shift    stem    either    cutting    sciences    skilled    phd    ideal    permanent    diagnostics    edge    establishing    departments    applies    medical    students    university    clinical    capacity    translational    centre    educate    assembling    leader    treatment    population   

Project "TransGeno" data sheet

The following table provides information about the project.

Coordinator
TARTU ULIKOOL 

Organization address
address: ULIKOOLI 18
city: TARTU
postcode: 51005
website: www.ut.ee

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Estonia [EE]
 Project website http://www.ctm.ee/era-chair/
 Total cost 2˙677˙500 €
 EC max contribution 2˙409˙700 € (90%)
 Programme 1. H2020-EU.4.c. (Establishing ‚ERA Chairs')
 Code Call H2020-WIDESPREAD-2014-2
 Funding Scheme CSA
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TARTU ULIKOOL EE (TARTU) coordinator 2˙409˙700.00

Map

 Project objective

TransGeno seeks to hire a top researcher as ERA Chair of Translational Genomics at the University of Tartu (UT). In addition to assembling a highly skilled team to engage in cutting edge translational genomic research, the ERA Chair will promote change throughout the university in several ways:

• Establishing the Centre of Translational Genomics as a permanent and sustainable unit within UT • Implementing a PhD curriculum on Translational Genomics - the first one of its kind in Eastern Europe. • Coordinate with other departments to make more efficient and effective use of UT’s research capacity. • Forge partnerships with leading institutions to attract top students and researchers from around the world as well as additional funding.

The ERA Chair will also engage with various stakeholders, including:

• Health sector business clusters to explore ways to exploit research results • Medical doctors to educate them on how one form of TG information, clinical genomic data, can be useful in everyday practice. • Youth and the general public to popularize genomics and spur young people into STEM sciences. • International researchers by sharing research data and results in as open way as possible, either at ‘green’ or ‘gold’ open access standards.

TG applies innovations from genomics to diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. It enables scientists to understand the genetic components of disease, which could lead to a shift from treatment based on symptoms to treatment based on underlying causes of disease. As Europe’s population ages and people must live with chronic diseases for longer this becomes more important. Advances in TG research could lead to early treatment of diseases and in the most ideal scenarios, enable doctors to treat patients before the onset of disease. TransGeno will increase research excellence in Estonia and enable UT to become a world leader in these efforts.

 Deliverables

List of deliverables.
Research team job descriptions Documents, reports 2019-05-30 12:46:24
Statement on Publications introduced in the reporting tool Documents, reports 2019-05-30 12:46:16
Report on ERA Chair employment Documents, reports 2019-05-30 12:46:23
ERA Chair job description Documents, reports 2019-05-30 12:46:22
Data Management Plan Documents, reports 2019-05-30 12:46:17
Annual progress report 1 Documents, reports 2019-05-30 12:46:29
ERA Chair Contract Executed Documents, reports 2019-05-30 12:46:25
Annual progress report 3 Documents, reports 2019-04-30 15:09:22
Updated Dissemination and Exploitation Plan Documents, reports 2019-04-30 15:09:21
PhD Curriculum for Translational Genomics Documents, reports 2019-04-30 15:09:22
Training materials for internal workshops Documents, reports 2019-04-30 15:09:21
Research team Contracts Executed Documents, reports 2019-04-30 15:09:22
Training materials for 8 seminars on genomics research and clinical genomics Documents, reports 2019-04-30 15:09:22
Training manuals for 3 international summer schools Documents, reports 2019-04-30 15:09:21
Database with 300 animal samples Other 2019-04-30 15:09:21
Annual progress report 2 Documents, reports 2019-04-30 15:09:22
Database with 1,000 human samples clinical and laboratory data Other 2019-04-30 15:09:21
Re-designed CTG Website Websites, patent fillings, videos etc. 2019-04-30 15:09:21
UT TG Research Integration Plan Documents, reports 2019-04-30 15:09:20

Take a look to the deliverables list in detail:  detailed list of TransGeno deliverables.

 Publications

year authors and title journal last update
List of publications.
2017 Lidiia Zhytnik, Katre Maasalu, Ene Reimann, Ele Prans, Sulev Kõks, Aare Märtson
Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients
published pages: , ISSN: 1479-7364, DOI: 10.1186/s40246-017-0115-5
Human Genomics 11/1 2019-07-02
2018 Stefan Blunder, Sulev Kõks, Gea Kõks, Ene Reimann, Hubert Hackl, Robert Gruber, Verena Moosbrugger-Martinz, Matthias Schmuth, Sandrine Dubrac
Enhanced Expression of Genes Related to Xenobiotic Metabolism in the Skin of Patients with Atopic Dermatitis but Not with Ichthyosis Vulgaris
published pages: 98-108, ISSN: 0022-202X, DOI: 10.1016/j.jid.2017.08.036
Journal of Investigative Dermatology 138/1 2019-07-02
2017 A. Van Soom, A. Fazeli
COST-Action GEMINI and EPICONCEPT: what we learned after 8 years?
published pages: 630-634, ISSN: 1984-3143, DOI: 10.21451/1984-3143-AR1007
Animal Reproduction 14/3 2019-07-02
2017 Anu Planken, Lille Kurvits, Ene Reimann, Liis Kadastik-Eerme, Külli Kingo, Sulev Kõks, Pille Taba
Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin
published pages: , ISSN: 1471-2377, DOI: 10.1186/s12883-016-0784-z
BMC Neurology 17/1 2019-07-02

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRANSGENO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TRANSGENO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.4.c.)

NANOPLANT (2019)

The creation of the Department of Plant Nanotechnology to maximise the impact of the ERA Chair culture on the IPG PAS

Read More  

R-Exposome Chair (2019)

R-Exposome Chair: Unlocking the potential of RECETOX in Exposome research

Read More  

Chaperon (2019)

ERA Chair Position for Excellent Research in Oncology

Read More